| Dr Richard H Hoffman, MD | |
|
2500 Pocoshock Pl Ste 104, Richmond, VA 23235-6345 | |
| (804) 276-9305 | |
| (804) 674-4145 |
| Full Name | Dr Richard H Hoffman |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 2500 Pocoshock Pl Ste 104, Richmond, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255426029 | NPI | - | NPPES |
| 5644496 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101039102 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Midlothian, VA | Home health agency |
| At Home Care | Richmond, VA | Home health agency |
| Bon Secours St Marys Hospital | Richmond, VA | Hospital |
| Bon Secours St Francis Medical Center | Midlothian, VA | Hospital |
| Cjw Medical Center | Richmond, VA | Hospital |
| Bon Secours Richmond Community Hospital | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bon Secours St Francis Medical Center Llc | 0648215418 | 29 |
| Bon Secours Medical Group Richmond Primary Care Llc | 3476986613 | 70 |
News Archive
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that researchers from Pfizer, Inc. presented data on in vivo activity of PF-04523655 at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, being held May 2-6, 2010 in Fort Lauderdale.
UK cancer research is helping to deliver significant clinical improvements for cancer patients, according to a study published in the British Journal of Cancer.
After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.
› Verified 7 days ago
| Entity Name | Bon Secours St Francis Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356350391 PECOS PAC ID: 0648215418 Enrollment ID: O20050920000437 |
News Archive
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that researchers from Pfizer, Inc. presented data on in vivo activity of PF-04523655 at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, being held May 2-6, 2010 in Fort Lauderdale.
UK cancer research is helping to deliver significant clinical improvements for cancer patients, according to a study published in the British Journal of Cancer.
After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.
› Verified 7 days ago
| Entity Name | Bon Secours Medical Group Richmond Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477112225 PECOS PAC ID: 8022440056 Enrollment ID: O20191113002170 |
News Archive
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that researchers from Pfizer, Inc. presented data on in vivo activity of PF-04523655 at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, being held May 2-6, 2010 in Fort Lauderdale.
UK cancer research is helping to deliver significant clinical improvements for cancer patients, according to a study published in the British Journal of Cancer.
After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.
› Verified 7 days ago
| Entity Name | Bon Secours Medical Group Richmond Primary Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861050635 PECOS PAC ID: 3476986613 Enrollment ID: O20191203000156 |
News Archive
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that researchers from Pfizer, Inc. presented data on in vivo activity of PF-04523655 at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, being held May 2-6, 2010 in Fort Lauderdale.
UK cancer research is helping to deliver significant clinical improvements for cancer patients, according to a study published in the British Journal of Cancer.
After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard H Hoffman, MD 2500 Pocoshock Pl Ste 104, Richmond, VA 23235-6345 Ph: (804) 276-9305 | Dr Richard H Hoffman, MD 2500 Pocoshock Pl Ste 104, Richmond, VA 23235-6345 Ph: (804) 276-9305 |
News Archive
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that researchers from Pfizer, Inc. presented data on in vivo activity of PF-04523655 at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, being held May 2-6, 2010 in Fort Lauderdale.
UK cancer research is helping to deliver significant clinical improvements for cancer patients, according to a study published in the British Journal of Cancer.
After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.
› Verified 7 days ago
Dr. Mary Mcfaden Caldwell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15000 Capital One Dr, 12078 Health Center, Richmond, VA 23238 Phone: 804-855-6000 | |
Dr. Zaroh L Neth, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Shockoe Slip, Ste 200, Richmond, VA 23219 Phone: 888-364-2334 Fax: 804-207-8833 | |
Mrs. Harriet Schanzer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6439 Iron Bridge Rd, Richmond, VA 23234 Phone: 804-271-8990 Fax: 804-271-9020 | |
William Edward Noller, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4620 S Laburnum Ave, Richmond, VA 23231 Phone: 804-652-2200 Fax: 804-222-0458 | |
Angela D Middleton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Glenside Dr, Suite 110, Richmond, VA 23226 Phone: 804-288-1800 Fax: 804-288-0515 | |
Dr. Reuben Hancock Broaddus Jr., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 511 Glendale Dr, Richmond, VA 23229 Phone: 804-740-1604 | |
Dr. Randolph Harris Palmore, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 N Hamilton St, Suite A, Richmond, VA 23221 Phone: 804-359-6880 Fax: 804-359-0611 |